Navigation Links
Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
Date:12/5/2007

BETHESDA, Md., Dec. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammation and autoimmune diseases, today announced that Dr. Christian Itin, President and Chief Executive Officer of Micromet, will be part of a panel discussion titled "Delivering On The Promise Of Antibody Therapies For Cancer" at the 2007 RBC Capital Markets Healthcare Conference in New York, on Wednesday, December 12, 2007 at 3:30pm Eastern Time (9:30pm Central European Time).

An audio webcast of Dr. Itin's remarks will be available live and accessible through Micromet's website at http://www.micromet-inc.com, as well as a replay and download of the presentation slides following the event.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are in clinical development. MT103 (MEDI-538), the first antibody developed using the BiTE(R) technology platform to be clinically validated in Micromet's product pipeline, is being evaluated in a phase 1 clinical trial for the treatment of patients with non- Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, a subsidiary of AstraZeneca plc. The second clinical stage antibody is adecatumumab (MT201), a human monoclonal antibody targeting EpCAM expressing tumors. Adecatumumab is being developed by Micromet in collaboration with Merck Serono, a division of Merck KGaA in Darmstadt, Germany, in a phase 1b clinical trial evaluating MT201 in combination
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCal...nnounced effective today it will reduce its workfo..., Dave DiGiacinto, President and Chief Operating... necessary action to reduce our cost structure to ...se financial condition as we discussed in our rece...
(Date:11/20/2008)... , Innovative consumer li...liday gift for 2008. Now available through Dick,s ...Pittsburgh, PA (Vocus) November 20, 2008 -- BodyM... monitoring systems, today announced the launch of...ement system that helps consumers monitor their bo...
(Date:11/20/2008)... PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-First... ) ("BMP Sunstone" or the "Company") today announc...ngshan) Pharmaceutical Co., Ltd,("Sunstone"), has..." a liquid-,filled hard capsule (LFHC) used to tr... entire LFHC filling and sealing production line, ...
(Date:11/20/2008)... LONGMONT, Colo., Nov. 20 MicroPh...ounced it has concluded its latest round,of finan...lion. Investors in,this round were a combination...e have come from private investors. , Micro...lete the validation,and launch preparation of the...
Breaking Biology Technology:MINRAD International, Inc. Announces Reduction in Workforce 2BodyMedia, Inc. Launches GowearFit, the First Direct-to-Consumer Lifestyle and Calorie Management System 2BodyMedia, Inc. Launches GowearFit, the First Direct-to-Consumer Lifestyle and Calorie Management System 3BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 3MicroPhage Closes Latest Financing 2
...traveled to an event in Madison, Wis. that was org...Network. It was designed to bring together three g...on: Madison, Milwaukee and of course Chicago. , ,...t the first to go on the road), the idea is derive...n come together to meet each other for a very quic...
...arket has been steadily advancing. People are star...olios once again. This is happening in spite of th...obs in the US are disappearing, and most will neve...ve years the US economy could be in real big troub...sing trade imbalances with countries such as China...
...ote: "FORWARD VISIONS" Today we begin three weeks...will appear on the Wisconsin Technology Network (W...gned to stimulate awareness, discussion and debate...oughts and technologies surrounding Wisconsin,s He...mber 1-7. WTN will publish EXCLUSIVE articles and ...
...must transition itself to the information age simi...ars ago to increase the productivity of our staff,... This transformation process is a considerable en...to look inward and understand how they operate and...e healthcare. , ,I will speak about my neck of the...
Other Biology Technology:Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3The Next Economy - Market Collapses Drive Long-Term Growth 2Why Wisconsin Lags Behind the U.S. and Minnesota 2Why Wisconsin Lags Behind the U.S. and Minnesota 3Why Wisconsin Lags Behind the U.S. and Minnesota 4Why Wisconsin Lags Behind the U.S. and Minnesota 5Im Still Waiting for the Information Age in Healthcare 2Im Still Waiting for the Information Age in Healthcare 3
(Date:11/21/2008)..., , , , , , , ,...VIDEO: , Graduate student Sue Lynn Lau partic... is completing a PhD at Garvan Institute of Medica...tle of her... , , Click here for... , , , , , , , ...
(Date:11/21/2008)...f popular varieties of rice, which can withstand 2...in farmers, fields with flying colors. Several of ...by national and state seed certification agencies ...r crop losses because of flooding of up to 4 milli...eed 30 million people. , The flood-tolerant vers...
(Date:11/20/2008)...e becoming increasingly aware of toxic chemical ex...enol A in some baby bottles and lead in some toys,...oducts with personal chemical exposure and related...m the December issue of the Journal of Health and...e pollution with large-scale contamination and env...
(Date:11/20/2008)...cal Institute at St. Joseph,s Hospital and Medical...motions and the perception of illusory motion that...ik, PhD, director of the Laboratory of Behavioral ...tor of the Laboratory of Visual Neuroscience; Xoan...ted a study based on the Enigma painting, a visual...
Breaking Biology News(10 mins):The 2009 AAAS/Science dance contest winners are announced 2The 2009 AAAS/Science dance contest winners are announced 3The 2009 AAAS/Science dance contest winners are announced 4The 2009 AAAS/Science dance contest winners are announced 5The 2009 AAAS/Science dance contest winners are announced 6The 2009 AAAS/Science dance contest winners are announced 7From genes to farmers' fields 2From genes to farmers' fields 3Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 1Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 2Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 3Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results 4303 1Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results 4303 2Longevinex 28R 29 Found to be Superior to Green Tea Molecule in Independent Human Study 1648 1Longevinex 28R 29 Found to be Superior to Green Tea Molecule in Independent Human Study 1648 2Fatality rates increase with repeal of helmet laws MU study finds 15590 1Fatality rates increase with repeal of helmet laws MU study finds 15590 2
...e plague bacterium uses a single gene to out-fox i...arch published in the journal Proceedings of the N...that Photorhabdus bacteria produce an antibiotic w...immune systems use to defend themselves from attac...ractions are thought to be common in diseases, ver...
...rom magnetic resonance imaging (MRI) to computed t...and organs have become the primary tools physician... for effective treatment. , New, innovative data...sity will provide doctors with a dramatically impr...ommonly used. This patent-pending technology allow...
...ing symptoms cancer patients experience during che...ult for health care professionals to accurately as...ersity of Illinois at Chicago are studying fatigue...ts using a method successfully used to monitor beh... , The method is called "ecological momentary as...
...d possibly even more ?than humans do. , And remark...volutionary terms, it has many of the immune syste...ct, it is possible some of these were pioneered by...s in the world ?yet they may possess a set of gene...David Miller of the ARC Centre of Excellence in Co...
Other Biology News:Scientists discover rare 'gene-for-gene' interaction that helps bacteria kill their host 2Novel system developed to turn data into real-time, interactive 3-D images 2Cancer patients monitor fatigue in real time 2Corals -- More complex than you? 2Corals -- More complex than you? 3
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Rabbit polyclonal to ThPok ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 500 to the C-terminus of Human ThPok. (Note: the a
Biology Products: